Clinical Trial Update: A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)

View source ↗

Summary

A study to learn more about the long-term safety of Tofersen (Qalsody) in participants with SOD1-associated amyotrophic lateral sclerosis is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Qalsody (Tofersen)

Snippet

Sponsor: Biogen | Conditions: Amyotrophic Lateral Sclerosis | Status: RECRUITING